Challenges and opportunities for new protein crystallization strategies in structure-based drug design

By Grey Jessica Lynn   Thompson David H  

Expert Opinion on Drug Discovery, Vol. 5, Iss. 11, 2010-11 ,pp. : 1039-1045

Informa Healthcare

Access to resources Recommend Favorite

Recent Advances in the Structure-Based and Ligand-Based Design of IKK&bgr; Inhibitors as Anti-inflammation and Anti-cancer Agents

By  

Current Medicinal Chemistry, Vol. 21, Iss. 34, 2014-11 ,pp. : 3893-3917

Bentham Science Publishers

Access to resources Recommend Favorite

Structure-Based Design of Novel Anticancer Agents

By  

Current Cancer Drug Targets, Vol. 1, Iss. 1, 2001-05 ,pp. : 59-71

Bentham Science Publishers

Access to resources Recommend Favorite

Structure-Based Drug Design, Molecular Dynamics and ADME/Tox to Investigate Protein Kinase Anti-Cancer Agents

By  

Current Bioactive Compounds, Vol. 13, Iss. 3, 2017-07 ,pp. : 213-222

Bentham Science Publishers

Access to resources Recommend Favorite

Structure-Based Design, Synthesis and Molecular Modeling Studies of Thiazolyl Urea Derivatives as Novel Anti-Parkinsonian Agents

By  

Medicinal Chemistry, Vol. 8, Iss. 6, 2012-11 ,pp. : 1057-1068

Bentham Science Publishers

Access to resources Recommend Favorite